Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-06Clinical Trial Update: Enhancing Consent for Alzheimer's Research [NA]
Clinical trial update on enhancing consent for Alzheimer's research; completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants. [Phase 4]
A Phase 4 pilot study evaluated methylphenidate in participants with Alzheimer dementia; results have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180) [Phase 2]
A Phase 2 clinical trial update examining relationships between neuropsychological testing and imaging modalities in Alzheimer and Parkinson…
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Caring Light Project for Family Caregivers [Phase 2]
Phase 2 clinical trial update for Caring Light Project addressing Alzheimer's disease; trial completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Virtual Patient Behavioral Response Training for Family Caregivers [Phase 2]
Phase 2 trial update on a virtual patient behavioral response training program for family caregivers of Alzheimer disease patients; study co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support: [NA]
Clinical trial completed for a WiFi-based localization system to support caregivers of dementia patients; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: [18F]MC225-PET in Neurodegenerative Disease [Phase 1, Phase 2]
Early-phase trial update for [18F]MC225-PET imaging in neurodegenerative diseases, including Alzheimer’s disease and related conditions (Pha…
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of Posiphen in subjects with early Alzheimer…
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy [Phase 2]
A Phase 2 clinical trial investigating the influence of vascular burden, amyloid plaque, and tau protein in patients with vascular cognitive…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease [Phase 2]
Phase 2 trial updating safety and potential efficacy of Trappsol Cyclo in patients with early Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease [Phase 2, Phase 3]
Phase 2/Phase 3 trial update on PM012 tablet for Alzheimer's disease assessing optimal dosage/administration.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923 [Phase 1]
Phase 1 trial evaluating safety, tolerability, pharmacokinetics and receptor occupancy of BMS-984923 in Alzheimer's disease; results have be…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Environmental Design for Behavioral Regulation in People With Dementia [NA]
Clinical trial update for an environmental design approach aimed at behavioral regulation in people with dementia (Alzheimer's disease); stu…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway [EARLY_Phase 1]
Early-phase 1 trial assessing rapamycin's effect on the mTOR pathway in mild cognitive impairment and Alzheimer's disease has completed with…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial. [Phase 1, Phase 2]
Follow-up safety and efficacy study in subjects who completed the NEUROSTEM Phase I/IIa trial for Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Senolytic Therapy to Modulate Progression of Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating senolytic therapy to modulate progression of Alzheimer’s disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) Treatment for Alzheimer Patients [Phase 2]
A Phase 2 clinical trial evaluating transcranial magnetic stimulation (TMS) for Alzheimer disease has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Effect of CT1812 Treatment on Brain Synaptic Density [Phase 1, Phase 2]
Phase 1/2 trial update on CT1812 shows results for Alzheimer's disease; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients [Phase 1, Phase 2]
Phase 1/2 dose-finding biomarker trial of Posiphen in early Alzheimer's and Parkinson's patients completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease [Phase 2, Phase 3]
Phase 2/3 study of COR388 (Cortexyme) in Alzheimer's disease completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers [Phase 2]
Phase 2 clinical trial evaluating the effect of thiethylperazine (TEP) on amyloid beta drainage in early-to-mild Alzheimer’s disease; study …
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of Yangxue Qingnao Pills in mild to moderate Alzheimer's disease is in progress, wit…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating effects of THC-free CBD oil on agitation in patients with Alzheimer’s disease and related dementias.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial assessing AVP-786 for agitation in dementia of the Alzheimer's type has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Protecting Alzheimer Caregivers Using Technology Through Staying Sharp [Phase 1, Phase 2]
A Phase 1/2 clinical trial exploring technology-based interventions to support Alzheimer’s caregivers and address caregiver burden in indivi…